Amgen has announced a significant expansion of a manufacturing facility in the US state of Ohio, with an investment of $900m.

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid ...

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an eight-week period.

Amgen expands apprenticeship program with Columbus State, adding advanced manufacturing training options for Central Ohio residents and new hires.

Amgen will invest $900M to expand its Columbus region biomanufacturing facility, bringing total investment in Central Ohio to over $1.4B.

THOUSAND OAKS, Calif., April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to ...

Amgen also alleges that Shanghai Henlius and Organon failed to comply with the BPCIA’s “patent dance” by withholding key manufacturing information.

The phase 3 FORTITUDE-101 trial, conducted with the support of Zai Lab, has been evaluating bemarituzumab plus mFOLFOX6 ...

NEW ALBANY, Ohio (WCMH) — Biotechnology company Amgen announced a $900 million manufacturing expansion in Ohio on Friday, bringing 350 new jobs to central Ohio. Lt. Gov. Jim Tressel joined Am… ...

THOUSAND OAKS, Calif., April 25, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number of jobs created to ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid ...